Type of leukemia-Chronic Myeloid Leukemia (CML) Posts on Medivizor

Posted by Medivizor on Dec 30, 2022 in Leukemia | 0 comments

In a nutshell This study evaluated the long-term effectiveness and safety of bosutinib (Bosulif) versus imatinib (Gleevec) in patients with newly diagnosed chronic phase (CP) chronic myeloid leukemia (CML). The data showed that bosutinib had better effectiveness than imatinib in these patients. Some background CML is a type of cancer that starts...

Posted by Medivizor on Feb 21, 2021 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the long-term outcomes of nilotinib (Tasigna) versus imatinib (Gleevec) in patients with chronic-phase chronic myeloid leukemia (CP-CML).  This study concluded that nilotinib provided good long-term outcomes for these patients.   Some background CML results from a gene...

Posted by Medivizor on Sep 6, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate treatment outcomes with transplant and tyrosine kinase inhibitors for childhood chronic myeloid leukemia.  This study concluded that some tyrosine kinase inhibitors provide better outcomes for these patients.  Some background Chronic myeloid leukemia (CML) is a rare disease in childhood....

Posted by Medivizor on May 24, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate second treatments in patients with chronic myeloid leukemia (CML) who had been initially treated with second-generation tyrosine kinase inhibitors (TKI).  This study concluded that switching from second-generation TKIs in these patients was relatively uncommon.   Some background...